RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Compliance and Start-ups

In Focus: Compliance and Start-ups

Posted 01 May 2010

Start-up companies and others in the early phases of drug, biologic and device development face a variety of issues and pitfalls. In addition to obtaining financing, these firms need an effective strategy and tactics to get from one milestone to the next. During this process, the company must, of course, follow the rules and regulations associated with bringing the product to market.

 

© 2022 Regulatory Affairs Professionals Society.